Establishment Labs Buy Hold or Sell Recommendation

ESTA -- USA Stock  

USD 21.05  0.11  0.53%

Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding Establishment Labs Holdings is 'Cautious Hold'. Macroaxis provides Establishment Labs buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ESTA positions. The advice algorithm takes into account all of Establishment Labs available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from ESTA buy-and-hold prospective. Additionally see Establishment Labs Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Execute Advice
Sell Establishment LabsBuy Establishment Labs
Cautious Hold

Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Not Available
For the selected time horizon Establishment Labs Holdings has a mean deviation of 1.84, semi deviation of 0.0, standard deviation of 2.62, variance of 6.86, downside variance of 0.0 and semi variance of 0.0
Macroaxis buy, hold, or sell recommendation module can be used to complement current analysts and expert consensus on Establishment Labs. Our buy, hold, or sell suggestion engine makes use of analyzes the corporation potential to grow using all fundamental data market data available at the time. To make sure Establishment Labs is not overpriced, please confirm all Establishment Labs fundamentals including its Cash and Equivalents, and the relationship between Revenue and Current Ratio . Given that Establishment Labs has Shares Owned by Insiders of 49.34% , we urge you verify Establishment Labs Holdings market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Establishment Labs Trading Alerts and Improvement Suggestions

Establishment Labs generates negative expected return over the last 30 days
The company reported previous year revenue of 75.14M. Net Loss for the year was (29.03M) with profit before overhead, payroll, taxes, and interest of 36.12M.
The company currently holds about 31.87M in cash with (34.04M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.55.
Roughly 49.0% of the company shares are held by company insiders
Latest headline from Breast Reconstruction Market By Size, Research, Services With Mentor Worldwide, GROUPE SEBBIN, SAS, Establishment Labs, ALLERGAN, Sientra, POLYTECH Health Aesthetics GmbH, GC Aesthetics, IDEAL IMPLANT, Guangzhou Wanhe - Indian Columnist

Establishment Labs current analysts recommendations

Target Median Price40.00
Target Mean Price37.40
Recommendation Mean1.20
Target High Price41.00
Number Of Analyst Opinions5
Target Low Price29.00

Establishment Labs Returns Distribution Density

Mean Return0.05Value At Risk3.33
Potential Upside4.66Standard Deviation2.62
 Return Density 

Establishment Labs Greeks

Alpha over DOW
Beta against DOW=0.0036
Overall volatility
Information ratio =0.03

Establishment Labs Volatility Alert

Establishment Labs Holdings exhibits very low volatility with skewness of 0.78 and kurtosis of 1.83. However, we advise investors to further study Establishment Labs Holdings technical indicators to make sure all market info is available and is reliable.
 Better Than Average     
 Worse Than Average Compare Establishment Labs to competition

Establishment Labs Fundamental Vs Peers

FundamentalsEstablishment LabsPeer Average
Return On Equity(103.38)% (0.31)%
Return On Asset(24.12)% (0.14)%
Profit Margin(38.63)% (1.27)%
Operating Margin(43.17)% (5.51)%
Current Valuation421.81M16.62B
Shares Outstanding20.5M571.82M
Shares Owned by Insiders49.34% 10.09%
Shares Owned by Institutions24.47% 39.21%
Number of Shares Shorted639.37K4.71M
Price to Book7.97X9.51X
Price to Sales5.71X11.42X
Gross Profit36.12M27.38B
Net Income(29.03M)570.98M
Cash and Equivalents31.87M2.7B
Cash per Share1.55X5.01X
Total Debt24.41M5.32B
Debt to Equity45.30% 48.70%
Current Ratio3.94X2.16X
Book Value Per Share2.63X1.93K
Cash Flow from Operations(34.04M)971.22M
Short Ratio8.54X4.00X
Earnings Per Share(1.45)X3.12X
Number of Employees59518.84K
Market Capitalization429.27M19.03B
Z Score10.28.72
   Purchase by Jw Asset Management Llc of 2000 shares of Establishment Labs [view details]

Establishment Labs Market Momentum